Tim Fagan is a 16-year-old boy who had been rushed to New York University Medical Center for an emergency liver transplant in February of 2004. Daily injections of Epogen, a medication for the treatment of severe anemia, was given Fagan. However, there was no improvement in his red blood cell count. Moreover, the teen-ager would always complain of severe and painful muscle cramps everytime an injection was administered. Doctors were left in a quandary as to why the medication was not working. It took almost two months before the news broke out that the medication being adminitered was a counterfeit.
This wasn’t a case of a drug that was bought from a local drugstore but from a major natonal pharmacy chain. Something happened somewhere after the drug left the manufacturing company and before it’s arrival at the pharmacy. Some unscrupulous moneymakers had taken the low-dose vials of Epogen which cost $22 and relabeled them as high-dose versions to be sold at $455. About 110,000 fake vials made it to the market netting the counterfeiters a whopping $48 million.
You could only imagine the great danger this malpractice had posed in the health...